Rothschild & Co Redburn Sticks to Their Buy Rating for Thermo Fisher (TMO)
Rothschild & Co Redburn analyst Natalya Davies maintained a Buy rating on Thermo Fisher today and set a price target of $620.00.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to TipRanks, Davies is an analyst with an average return of -6.0% and a 20.00% success rate. Davies covers the Healthcare sector, focusing on stocks such as Merck & Company, Repligen, and Thermo Fisher.
In addition to Rothschild & Co Redburn, Thermo Fisher also received a Buy from Barclays’s Luke Sergott in a report issued on April 14. However, on April 2, Erste Group maintained a Hold rating on Thermo Fisher (NYSE: TMO).
Based on Thermo Fisher’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $12.22 billion and a net profit of $1.98 billion. In comparison, last year the company earned a revenue of $11.4 billion and had a net profit of $1.83 billion
Read More on TMO:
Disclaimer & DisclosureReport an Issue
- OpenAI Debuts GPT-Rosalind, Its First AI Model Built Exclusively for Scientists
- Trump names Erica Schwartz CDC Director
- Thermo Fisher price target lowered to $625 from $650 at Barclays
- Private Markets: Nuclear, hypersonics score nearly $800M in fresh capital
- Thermo Fisher announces collaboration with Precision Health Research
